Akanda Corp. (AKAN)
1.04
+0.12
(+13.06%)
USD |
NASDAQ |
Feb 27, 16:00
1.03
-0.01
(-0.96%)
After-Hours: 20:00
Akanda Research and Development Expense (Quarterly)
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| NovoCure Ltd. | 60.90M |
| LivaNova Plc | 51.50M |
| Alterola Biotech, Inc. | -- |
| Kiniksa Pharmaceuticals International Plc | 34.49M |
| Plus Therapeutics, Inc. | 2.436M |